Cargando…

Pharmacokinetic drug interactions with clopidogrel: updated review and risk management in combination therapy

BACKGROUND: Coprescribing of clopidogrel and other drugs is common. Available reviews have addressed the drug–drug interactions (DDIs) when clopidogrel is as an object drug, or focused on combination use of clopidogrel and a special class of drugs. Clinicians may still be ignorant of those DDIs when...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Zhi-Yu, Chen, Meng, Zhu, Ling-Ling, Yu, Lu-Shan, Zeng, Su, Xiang, Mei-Xiang, Zhou, Quan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373598/ https://www.ncbi.nlm.nih.gov/pubmed/25848291 http://dx.doi.org/10.2147/TCRM.S80437

Ejemplares similares

Pharmacokinetic drug interaction profile of omeprazole with adverse consequences and clinical risk management
por: Li, Wei, et al.
Publicado: (2013)

Pharmacokinetic drug–drug interactions between 1,4-dihydropyridine calcium channel blockers and statins: factors determining interaction strength and relevant clinical risk management
por: Zhou, Yi-Ting, et al.
Publicado: (2013)

Physiologically Based Pharmacokinetic Modeling Suggests Limited Drug–Drug Interaction Between Clopidogrel and Dasabuvir
por: Shebley, M, et al.
Publicado: (2017)

Pharmacokinetic and Pharmacodynamic Responses to Clopidogrel: Evidences and Perspectives
por: Zhang, Yan-Jiao, et al.
Publicado: (2017)

"Influence of methadone on clopidogrel in addicts on methadone maintenance therapy" Drug interaction between methadone and clopidogrel
por: Fallah, Ferigol, et al.
Publicado: (2016)

Opioid analgesics-related pharmacokinetic drug interactions: from the perspectives of evidence based on randomized controlled trials and clinical risk management
por: Feng, Xiu-qin, et al.
Publicado: (2017)

Effect of Sijunzi Pills on Pharmacokinetics of Omeprazole in Beagle Dogs by HPLC-UV: A Herb-Drug Interaction Study
por: Xia, Hua-ling, et al.
Publicado: (2021)

Interaction of Dasabuvir With Clopidogrel: Did Predictions by Physiologically Based Pharmacokinetics Modeling Pass the Test?
por: Shebley, Mohamad
Publicado: (2018)

The Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel in Healthy Japanese Volunteers
por: Umemura, Kazuo, et al.
Publicado: (2016)

Pharmacokinetic, pharmacodynamic, and pharmacogenetic assays to monitor clopidogrel therapy
por: Alvitigala, Bhawani Yasassri, et al.
Publicado: (2020)

Pharmacokinetic Drug Interaction Profiles of Proton Pump Inhibitors: An Update
por: Wedemeyer, Ralph-Steven, et al.
Publicado: (2014)

Effects of the short-term application of pantoprazole combined with aspirin and clopidogrel in the treatment of acute STEMI
por: Wei, Peng, et al.
Publicado: (2016)

Evaluation of a Clinically Relevant Drug–Drug Interaction Between Rosuvastatin and Clopidogrel and the Risk of Hepatotoxicity
por: Ning, Chen, et al.
Publicado: (2021)

Clinical Pharmacokinetics of Clopidogrel and Its Metabolites in Patients with Cardiovascular Diseases
por: Karaźniewicz-Łada, Marta, et al.
Publicado: (2013)

Application of Physiologically Based Pharmacokinetic Modeling to Evaluate the Drug–Drug and Drug–Disease Interactions of Apatinib
por: Liu, Hongrui, et al.
Publicado: (2021)

Pharmacokinetic drug-drug interaction and their implication in clinical management
por: Palleria, Caterina, et al.
Publicado: (2013)

Pharmacokinetic and Drug–Drug Interaction Profiles of the Combination of Tezacaftor/Ivacaftor
por: Garg, Varun, et al.
Publicado: (2019)

Personalized therapeutics for levofloxacin: a focus on pharmacokinetic concerns
por: Gao, Chu-Han, et al.
Publicado: (2014)

Clopidogrel Pharmacokinetics in Malaysian Population Groups: The Impact of Inter-Ethnic Variability
por: Zakaria, Zaril H., et al.
Publicado: (2018)

SHR2285, the first selectively oral FXIa inhibitor in China: Safety, tolerability, pharmacokinetics and pharmacodynamics combined with aspirin, clopidogrel or ticagrelor
por: Ma, Tingting, et al.
Publicado: (2022)

The use of oral suspension and rationally prescribing alternatives may be supplemental to the implementation of clopidogrel new algorithm comprising CYP2C19 pharmacogenetics and drug interactions
por: Chen, Meng, et al.
Publicado: (2016)

Associations of PER3 polymorphisms with clopidogrel resistance among Chinese Han people treated with clopidogrel
por: Zheng, Nan, et al.
Publicado: (2021)

Pharmacokinetic and pharmacodynamic effects of comedication of clopidogrel and dabigatran etexilate in healthy male volunteers
por: Härtter, Sebastian, et al.
Publicado: (2012)

Effect of chronic unpredicted mild stress-induced depression on clopidogrel pharmacokinetics in rats
por: Jiang, Xueyao, et al.
Publicado: (2022)

Pharmacokinetics and relative bioavailability of fixed-dose combination of clopidogrel and aspirin versus coadministration of individual formulations in healthy Korean men
por: Choi, Hyang-Ki, et al.
Publicado: (2016)

Effects of Combined Aspirin and Clopidogrel Therapy on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis
por: Zhou, Yu-Hao, et al.
Publicado: (2012)

Relationship between high platelet reactivity on clopidogrel and long-term clinical outcomes after drug-eluting stents implantation (PAINT-DES): a prospective, propensity score-matched cohort study
por: Gao, Xiao-Fei, et al.
Publicado: (2018)

Smoking Interaction with Clopidogrel; Another Smoker's Paradox?
por: Ryu, Jae Kean
Publicado: (2010)

Simultaneous determination of clopidogrel, 2-oxo-clopidogrel, and the thiol metabolite of clopidogrel in human plasma by LC-MS/MS
por: Xu, Lei, et al.
Publicado: (2022)

Pharmacokinetic Study of Triptolide Nanocarrier in Transdermal Drug Delivery System—Combination of Experiment and Mathematical Modeling
por: Yang, Meng, et al.
Publicado: (2023)

Pharmacokinetic Drug–Drug Interactions and Herb–Drug Interactions
por: Choi, Min-Koo, et al.
Publicado: (2021)

Clinical, Pharmacokinetic, and Pharmacogenetic Determinants of Clopidogrel Resistance in Korean Patients with Acute Coronary Syndrome
por: Park, Kyoung-Jin, et al.
Publicado: (2011)

Synergistic Effects of Clopidogrel and Fufang Danshen Dripping Pills by Modulation of the Metabolism Target and Pharmacokinetics
por: Ma, Shitang, et al.
Publicado: (2014)

A Review of Danshen Combined with Clopidogrel in the Treatment of Coronary Heart Disease
por: Zhang, Zhaojian, et al.
Publicado: (2019)

Interaction between clopidogrel and proton-pump inhibitors and management strategies in patients with cardiovascular diseases
por: Gurbel, Paul A, et al.
Publicado: (2010)

A review of significant pharmacokinetic drug interactions with antidepressants and their management
por: Hoffelt, Charity, et al.
Publicado: (2016)

Is it appropriate regarding patient preference to take Myrtol standardized enteric-coated soft capsules after a meal rather than at fasted state? A food–drug pharmacokinetic interaction study in healthy Chinese volunteers
por: Zhao, Ting-Ting, et al.
Publicado: (2016)

Comment on “Association between CYP2C19 and ABCB1 polymorphisms and clopidogrel resistance in clopidogrel-treated Chinese patients”
por: Wang, Bin, et al.
Publicado: (2018)

A population-based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors
por: Cressman, Alex M, et al.
Publicado: (2015)

Multi-compound and drug-combination pharmacokinetic research on Chinese herbal medicines
por: Li, Chuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jer1mgibed9d3m99duca9f3g3f